TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER

Clinical trials for TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER trials appear

Sign up with your email to follow new studies for TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug attack on tough breast cancers

Disease control Recruiting now

This study is testing a new combination of two drugs for people with advanced breast cancer that has spread and is hard to treat. The main goals are to see if the combination is safe and if it can shrink or control the cancer. It will enroll about 50 people with specific types of…

Matched conditions: TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER

Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER

Get alerted when new TRIPLE NEGATIVE LOCALLY ADVANCED NON-RESECTABLE BREAST CANCER trials appear

New Two-Drug attack on tough breast cancers